Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke
Frank Leypoldt, Chi-Un Choe, Mathias Gelderblom et al. · 2009
Read Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke by Frank Leypoldt, Chi-Un Choe, Mathias Gelderblom et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007337.txt.
Description
Frank Leypoldt, Chi-Un Choe, Mathias Gelderblom, and colleagues tested a protective enzyme idea in stroke-prone mice in 2009. Methylated arginines interfere with nitric oxide formation, causing endothelial dysfunction in blood vessels. One such compound, ADMA, predicts cardiovascular events and death in humans, making its removal seem therapeutically attractive.
An enzyme called DDAH-1 breaks down ADMA. The authors study transgenic mice with extra DDAH-1. They report these mice are not protected from ischemic stroke. That negative result matters: lowering a risk marker does not always prevent the event. It redirects stroke prevention research toward other mechanisms.
Catalog record
| CREATOR | Frank Leypoldt, Chi-Un Choe, Mathias Gelderblom et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007337